Article Versions Notes

Seekins CA, Archuleta MR, Evans AE, Podgorski J, Carr JE, Kaleeswaran V, Nguyen KB, Flowers ME, Hulme C, Vanderah TW, et al. Barettin Suppresses Pancreatic Ductal Adenocarcinoma Proliferation via Topoisomerase IIα Inhibition. Marine Drugs. 2026; 24(6):201. https://doi.org/10.3390/md24060201

Seekins, Caleb A., Monique R. Archuleta, Alexandria E. Evans, Julia Podgorski, Jerry E. Carr, Vishal Kaleeswaran, Kayla B. Nguyen, Matthew E. Flowers, Christopher Hulme, Todd W. Vanderah, and et al. 2026. "Barettin Suppresses Pancreatic Ductal Adenocarcinoma Proliferation via Topoisomerase IIα Inhibition" Marine Drugs 24, no. 6: 201. https://doi.org/10.3390/md24060201

Seekins, C. A., Archuleta, M. R., Evans, A. E., Podgorski, J., Carr, J. E., Kaleeswaran, V., Nguyen, K. B., Flowers, M. E., Hulme, C., Vanderah, T. W., Cárdenas, P., Streicher, J. M., Lee, N. Y., & Cartmell, C. (2026). Barettin Suppresses Pancreatic Ductal Adenocarcinoma Proliferation via Topoisomerase IIα Inhibition. Marine Drugs, 24(6), 201. https://doi.org/10.3390/md24060201